SCHOTT Corporation Release: Interpack 2017: High-Quality Ampoules Join Forces With Latest Developments In Filling Lines
When the pharmaceutical industry meets at the Interpack trade show in Düsseldorf from May 4-10, 2017 to discover new fill & finish concepts, one well-established packaging category will offer new impetus.
“When it comes to drugs packed in glass ampoules we see that pharmaceutical companies are looking to further improve their filling operations to achieve higher yields. This is definitely a big trend in the market,” says SCHOTT product manager Neus Ferré. “For example, customers filling large quantities are looking for high-speed line concepts. Other customers processing smaller batches may be looking for flexible fill & finish concepts. Nevertheless, if pharma companies want to leverage the full potential of the new filling line developments, they need to combine these with ampoules that come with high and stable dimensional quality, ideally backed up by 100% inspection for the key dimensions,” Ferré says. Dedicated to customer driven product development, SCHOTT experts are in continuous contact with pharmaceutical companies and equipment vendors to learn about their challenges as regards the processing of the ampoules in order to translate those requirements into a smooth interplay between equipment and packaging. “High-quality ampoules are thus key to making the most out of the new generation of filling lines,” confirms Markus Hörsch, Sales Director at Bausch + Ströbel.
Glass ampoules are still widely used to package injectable drugs, and the demand is even growing in emerging markets. “After all, they offer a safe, efficient and cost competitive solution to set up basic healthcare coverage,” says Neus Ferré. “When using ampoules, there is only one type of material – glass – in contact with the drug, and it is easy to tell if the container closure integrity is intact,” she adds. The advent of new filling concepts underlines the fact that ampoules have gained new momentum. “Ampoules have been on the market for more than 80 years and are often said to be on the decline. However, we still see a lot of movement in this market, especially in improvements focused on fill & finish operations,” says Ferré.
Visitors can see SCHOTT ampoules in conjunction with Bausch + Ströbel’s latest addition to the highly flexible VarioSys platform, the AFV5105 ampoule processing module, in hall 16, booth D14.
SCHOTT is a leading international technology group in the areas of specialty glass and glass-ceramics. The company has more than 130 years of outstanding development, materials and technology expertise and offers a broad portfolio of high-quality products and intelligent solutions. SCHOTT is an innovative enabler for many industries, including the home appliance, pharma, electronics, optics, life sciences, automotive and aviation industries. SCHOTT strives to play an important part of everyone’s life and is committed to innovation and sustainable success. The group maintains a global presence with production sites and sales offices in 34 countries. With its workforce of approximately 15,000 employees, sales of 1.99 billion euros were generated in fiscal year 2015/2016. The parent company, SCHOTT AG, has its headquarters in Mainz (Germany) and is solely owned by the Carl Zeiss Foundation. As a foundation company, SCHOTT assumes special responsibility for its employees, society and the environment. www.schott.com
“When it comes to drugs packed in glass ampoules we see that pharmaceutical companies are looking to further improve their filling operations to achieve higher yields. This is definitely a big trend in the market,” says SCHOTT product manager Neus Ferré. “For example, customers filling large quantities are looking for high-speed line concepts. Other customers processing smaller batches may be looking for flexible fill & finish concepts. Nevertheless, if pharma companies want to leverage the full potential of the new filling line developments, they need to combine these with ampoules that come with high and stable dimensional quality, ideally backed up by 100% inspection for the key dimensions,” Ferré says. Dedicated to customer driven product development, SCHOTT experts are in continuous contact with pharmaceutical companies and equipment vendors to learn about their challenges as regards the processing of the ampoules in order to translate those requirements into a smooth interplay between equipment and packaging. “High-quality ampoules are thus key to making the most out of the new generation of filling lines,” confirms Markus Hörsch, Sales Director at Bausch + Ströbel.
Glass ampoules are still widely used to package injectable drugs, and the demand is even growing in emerging markets. “After all, they offer a safe, efficient and cost competitive solution to set up basic healthcare coverage,” says Neus Ferré. “When using ampoules, there is only one type of material – glass – in contact with the drug, and it is easy to tell if the container closure integrity is intact,” she adds. The advent of new filling concepts underlines the fact that ampoules have gained new momentum. “Ampoules have been on the market for more than 80 years and are often said to be on the decline. However, we still see a lot of movement in this market, especially in improvements focused on fill & finish operations,” says Ferré.
Visitors can see SCHOTT ampoules in conjunction with Bausch + Ströbel’s latest addition to the highly flexible VarioSys platform, the AFV5105 ampoule processing module, in hall 16, booth D14.
SCHOTT is a leading international technology group in the areas of specialty glass and glass-ceramics. The company has more than 130 years of outstanding development, materials and technology expertise and offers a broad portfolio of high-quality products and intelligent solutions. SCHOTT is an innovative enabler for many industries, including the home appliance, pharma, electronics, optics, life sciences, automotive and aviation industries. SCHOTT strives to play an important part of everyone’s life and is committed to innovation and sustainable success. The group maintains a global presence with production sites and sales offices in 34 countries. With its workforce of approximately 15,000 employees, sales of 1.99 billion euros were generated in fiscal year 2015/2016. The parent company, SCHOTT AG, has its headquarters in Mainz (Germany) and is solely owned by the Carl Zeiss Foundation. As a foundation company, SCHOTT assumes special responsibility for its employees, society and the environment. www.schott.com